PLATELET ANTIAGGREGATORY ACTIVITY AND ANTITHROMBOTIC THERAPY EFFICIENCY IN PATIENTS WITH CORONARY HEART DISEASE AND TYPE 2 DIABETES MELLITUS IN RELATION TO GENDER

Download full text PDF
Issue: 
12
Year: 
2015

L. Nikolenko (1), Candidate of Medical Sciences; E. Golovneva (2), MD 1 -Federal Center of Cardiovascular Surgery, Chelyabinsk 2 -South Ural State Medical University, Chelyabinsk

Impaired platelet function plays a leading role in the pathogenesis of angina pectoris, one of the major clinical forms of coronary heart disease, which determines the relevance of a study of the mechanisms of platelet adhesion and aggregation. Today antithrombotic therapy is the most important component of the primary and secondary prevention of cardiovascular diseases. The fact that it is possible to make a laboratory evaluation of the effects of platelet aggregation inhibitors widely used during preparation for stenting assumes a special sociomedical importance.
Keywords: 
aggregation
platelets
coronary heart disease
antithrombotic therapy

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Nizovtseva O.A. Kompleksnaja terapija serdechno-sosudistyh zaboleva nij i defitsit magnija // Trudnyj patsient. – 2014; 7: 45–8.
  2. Grigorjan O.R., Andreeva E.N. Menopauznyj sindrom u zhenschin s naru shenijami uglevodnogo obmena. Vzgljad ginekologa-endokrinologa // Trudnyj patsient. – 2007; 5 (9): 29–34.
  3. Whiteley L., Padmanabhan S., Hole D. et al. Should Diabetes Be Coronary Heart Disease Risk Equivalent? Results from 25 years of follow-up in the Renfrew and Paisley Survey // Diabetes Care. – 2005; 28: 1588–93,
  4. Ajnetdinova D.H., Udovichenko A.E., Sulimov V.A. Rol' antitrombo tsitarnoj terapii v pervichnoj i vtorichnoj profilaktike serdechno-sosudistyh zabolevanij // Effektivnaja farmakoterapija v kardiologii i angiologii. – 2007; 2: 36–41.
  5. Helgason C., Grossi E., Pandey D. et al. Platelet aggregation and recruitment with aspirin-clopidogrel therapy // Cerebrovasc. Dis. – 2008; 25 (5): 392–400.
  6. Harrison R., Frelinger A., Furman M. et al. Measuring antiplatelet drug effects in the laboratory // Thromb. Research. – 2007; 120: 323–36.
  7. Grigorjan O.R., Antsiferov M.B. Zamestitel'naja gormonal'naja terapija u zhenschin, bol'nyh saharnym diabetom, v period peri- i postmenopauzy. Ruk-vo dlja vrachej / M., 2001; 16 s.
  8. Gurevich M.A., Mravjan S.R., Grigor'eva N.M. Ishemicheskaja bolezn' u zhenschin // Trudnyj patsient. – 2006; 4 (12): 5–11.
  9. Ravipati G., Aronow W., Ahn C. Association of hemoglobin A(1c) level with the severity of coronary artery disease in patients with diabetes mellutis // Am. J. Cardiol. – 2006; 97: 968–9.
  10. Kondrat'eva E.I., Suhanova G.A., Novitskij V.V. Gemostaz u detej i vzroslyh s SD // Detskaja endokrinologija. – 2007; 4: 50–3.
  11. Chu S., Becker R., Berger P. et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis // J. Thromb. Haemost. – 2010; 8 (1): 148–56.
  12. Harrison P. Platelet function analysis // Blood Rev. – 2005; 19: 111–23.12.
  13. Mazurov A.V., Haspekova S.G., Sirotkina O.V. i dr. Variatsii soderzha nija glikoproteina IIb-Sha (allb/betaZ integrina) u zdorovyh donorov. Vlijanie na agregatsionnuju aktivnost' trombotsitov i effektivnost' dejstvija aspi-rina // Biomeditsinskaja himija. – 2008; 3: 361–71.
  14. Marcucci R., Gori A., Paniccia R. et al. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up // Circulation. – 2009; 119 (1): 237–42.
  15. Landray M., Wheeler D., Lip G. et al. Inflammation, endothelial dysfunction, 15. and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study // Am. J. Kidney Diseas. – 2004; 43 (2): 244–53.
  16. Sibireva O.F., Koljuzhin V.V., Urazova O.I. Biohimicheskie markery 16. disfunktsii endotelija u patsientov s diabeticheskoj nefropatiej // Klin. lab. diag. – 2012; 8: 8–11.